NFA
LAB icon

Nationwide Fund Advisors’s Standard BioTools LAB Stock Holding History

Nationwide Fund Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-17,628
Closed -$89K – 1125
2017
Q3 		$89K Hold
17,628
– – ﹤0.01% 2944
2017
Q2 		$71K Hold
17,628
– – ﹤0.01% 3008
2017
Q1 		$100K Hold
17,628
– – ﹤0.01% 2845
2016
Q4 		$128K Sell
17,628
-1,852
-10% -$11.6K ﹤0.01% 2789
2016
Q3 		$156K Hold
19,480
– – ﹤0.01% 2742
2016
Q2 		$176K Hold
19,480
– – ﹤0.01% 2670
2016
Q1 		$157K Hold
19,480
– – ﹤0.01% 2636
2015
Q4 		$211K Buy
19,480
+697
+4% +$6.84K ﹤0.01% 2526
2015
Q3 		$152K Hold
18,783
– – ﹤0.01% 2708
2015
Q2 		$455K Sell
18,783
-1,756
-9% -$55.4K ﹤0.01% 2297
2015
Q1 		$865K Sell
20,539
-885
-4% -$35K ﹤0.01% 1957
2014
Q4 		$723K Sell
21,424
-193
-0.9% -$5.47K ﹤0.01% 1983
2014
Q3 		$530K Buy
21,617
+93
+0.4% +$2.62K ﹤0.01% 2175
2014
Q2 		$633K Sell
21,524
-27,919
-56% -$895K ﹤0.01% 2128
2014
Q1 		$2.18M Buy
49,443
+18,208
+58% +$801K 0.01% 1310
2013
Q4 		$1.2M Buy
31,235
+10,998
+54% +$324K 0.01% 1770
2013
Q3 		$444K Buy
20,237
+1,469
+8% +$28.9K ﹤0.01% 2281
2013
Q2 		$328K Buy
+18,768
New +$329K ﹤0.01% 2246

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nationwide Fund Advisors's LAB Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Standard BioTools (LAB) in Q4 2017, closing a stake of 17,628 shares — an estimated $89K sold.

Nationwide Fund Advisors first reported a position in LAB in Q2 2013 and held it in 18 quarters. The position peaked at $2.18M in Q1 2014. 81 funds tracked by Wall St. Rank hold LAB as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Standard BioTools position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 17,628 Standard BioTools shares in Q4 2017, an estimated $89K.
  • Nationwide Fund Advisors first reported a position in Standard BioTools in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Standard BioTools position peaked at $2.18M in Q1 2014.
  • 81 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.